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Summary 
Induction of T  cell responses to an antigenic peptide that is known to bind a major histocom- 
patibility complex molecule is a function of either the T cell receptor (TCI<) repertoire or reg- 
ulatory influences by CD8 or CD4 regulatory T cells. We have tested the hypothesis that a lack 
of 10 TC1L V~ gene segments in Vf3  a mice may result in an incomplete repertoire of regulatory 
T cells involved in maintaining peripheral tolerance. Such a hole in the repertoire of regulatory 
cells could result in expression of T  cell responses to antigenic determinants that normally re- 
main undetected in mice with a wild-type repertoire of TCR V~ gene segments. We show 
here that H-2  a mice respond to the peptide 74-96 of hen egg-white lysozyme (HEL) when 
they are ofV~  a haplotype at their TCR locus. The wild-type (g~ b) H-2  a mice with their com- 
plete set of 20 TC1L V~3 gene segments fail to respond to HEL 74-96. The 74-96-specific T 
cell responsiveness was revealed in the wild-type (V~3  b) mice when they were treated in vivo 
with anti-CD8 antibody, implicating the existence ofregnlatory cells that prevent expression of 
T  cell responses specific for peptide 74-96. This is a demonstration that holes in the regulatory 
T  cell repertoire can, in certain circumstances, become beneficial to the host, for example, in 
susceptibility against  pathogens. 
D 
ue to the loss of 10 T  cell receptor V~3 gene segments 
from  their  germline  repertoire,  V~  a mice  possess  a 
truncated  TCP.  repertoire  (1,  2).  We  have  previously 
shown  that  mice with  such  a  deletion in  their TCP.  Vr 
genes (V~ truncated haplotype, Vf3  ~) are unable to respond 
to  two  antigenic  determinants  (sperm  whale  myoglobin 
[SWMp  110-121/E~,aAr a and myelin basic  protein [MBP] 
1-11/A  ~  (2).  These experiments indicated that there is an 
absolute limit to the flexibility inherent in the TCR reper- 
toire:  the absence of specific TCR V~ gene segments re- 
sulted in holes in T  cell responsiveness to the above-men- 
tioned determinants (2, 3). 
One mechanism for maintenance of peripheral tolerance 
to self- and foreign antigens  involves regulatory cells  that 
inhibit  the  function  of antigen-specific T  cells  such  that 
there is no response upon immunization with specific pep- 
tide or protein antigens despite the existence of T  cells that 
can  recognize their determinants.  Peripheral  tolerance to 
self-peptides exists to prevent autoreactivity by T  cells that 
have  escaped deletion during thymic selection (4-6).  Pe- 
ripheral  tolerance to  foreign antigens  is likely to  exist to 
prevent  immune  pathology caused  by  the  persistence  of 
~Abbreviations used in this paper: HEL,  hen egg-white  lysozome;  MBP, my- 
elin basic protein; Pal, recombinant  inbred; SWM, sperm whale myoglobin. 
certain activated T cells, for example in several parasitic sys- 
tems (7). Peripheral tolerance or suppression to foreign an- 
tigens  could also  exist as  a fortuitous consequence of the 
cross-reactivity of self-directed regulatory cells.  Thus,  (a) 
many  foreign  antigen  determinants  associated  with  self- 
MHC molecules are structural mimics of MHC-restricted 
self-determinants  and  thus  should  be  susceptible  to  the 
same regulation as self-antigens (8), and (b) certain foreign 
and  self-determinants  induce  T  cells  bearing  similar  or 
identical TCR V  region gene segments (3, 9).  TCtl_-cen- 
tered regulatory cells that recognize specific TCR determi- 
nants  may therefore be  able to regulate both foreign and 
self-antigens through TCR-targeted circuitry (for reviews 
see references 9 and 10). 
We hypothesized that regulatory cells controlling the ex- 
pression  of immune  responsiveness  toward  certain  anti- 
genic determinants might also have a limited T  cell reper- 
toire.  Thus,  a lack of 10  TCP, Vf3 gene segments in V~3" 
mice could possibly give rise  to holes in the repertoire of 
the regulatory cells, analogous to the holes in the repertoire 
ofSWM 110-121/E~dA~ d- and MBP 1-11/Au-specific CD4 
T  cells that we had previously reported. The outcome of 
such a hole in the repertoire of regulatory cells would be 
the expression of T  cell responsiveness to normally nonim- 
munogenic determinants. 
We show in this report that a strong T cell response, spe- 
cific for peptide 74-96 of hen egg-white lysozyme (HEL), 
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gene segments, presumably encoding a TCR  [3 chain on a 
potent regulatory T  cell. None  of the three strains of H-2 a 
mice  (BALB/c, B10.D2,  and FI[BALB/c ￿  SJL]) with an 
intact repertoire of 20 TCR  V~ gene segments responds to 
the peptide HEL 74-96.  However, two  different H-2 d re- 
combinant  inbred mouse  strains  ([CxJ]9,  [CxJ]8)  with the 
V~  :~,  truncated  set  of TCR  V~  gene  segments  show  very 
strong  T  cell  responses  to  this  peptide.  Furthermore,  al- 
though  74-96-specific  long-term  CD4 +  T  cell  lines  and 
clones  can  be  readily derived  from  V~  a mice,  it  was  not 
possible to obtain such a long-term T  cell line from BALB/c 
(V~  t')  mice  (data  not  shown).  We  also  show  that  in  vivo 
treatment  with  anti-CD8  antibodies  of  nonresponsive, 
wild-type V~  6 mice, allows expression of T  cell responsive- 
ness to HEL 74-96. These results reveal a hole in the regu- 
latory repertoire of CD8  T  cells in  V~ a mice  that  usually 
controls the response to HEL 74-96. 
Materials  amd Methods 
Mice.  Mice either were bred at our own laboratory or were 
obtained from The Jackson Laboratory (Bar Harbor, ME). 
Antigens and Peptides.  Hen egg lysozyme was purified as de- 
scribed earlier (2).  Peptide  74-96  was  synthesized in  bulk  and 
HPLC purified in bulk by Macromolecular Resources (Ft. Col- 
tins,  CO)  in two batches. The sequence of HEL 74-96  (NLC- 
NIPCSALLSSDITASVNCAK) includes three cysteine residues. 
One batch of 74-96 was synthesized with the usual cysteine resi- 
dues, whereas the other batch contained a replacement by o~-amino- 
butyric acid instead ofcysteine in each of the three positions. The 
two batches of 74-96 showed identical responses in all assays (data 
not shown) and were used interchangeably. The pepscan series of 
truncated  and  extended  peptides  within  the  sequence  69-104 
were  made by synthesis on  pins followed by cleavage into  96- 
well plates (11). 
Antibodies.  Anti-CD8  antibody  (clone  53-6.7,  a  rat  IgG2a 
antibody) and an isotype control antibody, rat  IgG2a  (rlgG2a), 
were obtained from PharMingen (San Diego, CA). FITC-conju- 
gated nmrine anti-CD8 antibody (clone 53-6.7) and FITC-con- 
jugated  isotype  control  antibody  were  obtained  from  Becton 
Dickinson & Co. (San Jose, CA). 
hi  Vivo Depletion qfl CD8 T Cells.  125  bLg of anti-CD8  anti- 
body in  PBS was  injected intraperitoneally into  BALB/c mice. 
The control groups were injected either with 125 btg of rat IgG2a 
(PharMingen) in PBS or with PBS alone. 
ImnlunqflltOn'scence.  hnmunofluorescence  on  LN  or  splenic 
cells was performed and analyzed as described earlier (2). 
Immunization.  Mice were inmmnized with 7 nmol ofpeptide 
or protein antigen in the hind footpads with an e:nulsion of CFA 
(H37Ra;  Difco Laboratories, Detroit, MI).  On  day 9,  LN cells 
(LNC)  from  draining LN were  harvested and  used  in  antigen- 
induced proliferation assays or as a source  of T  cells to generate T 
cell hybridomas. 
Generation 0f T Cell Hybrids.  T  cell hybridomas were gener- 
ated from mice immunized with peptide 74-96 as described be- 
fore (2) except that LNC were harvested and bulk cultured with 
the peptide 74-96  for only one  cycle of stinmlation before hy- 
bridization. Thus, LNC cultured for 6 d with peptide 74-96 were 
further cultured for 3 d with rlL-2. T  cell blasts were then puri- 
fied by Ficoll-Hypaque density centrifugation and fused with a 
variant ofBW5147, BW/o~  [3  (2, 11) as a fusion partner, as de- 
scribed before. The resulting hybrids were seeded at less than one 
cell per well in 96-well plates; the positive wells were expanded 
and tested for their ability to produce IL-2 using HT-2 cells (IL-2 
dependent) in response to peptide 74-96 and HEL. The antigen- 
reactive hybrids were further expanded and analyzed for function. 
Specificity Assays.  For antigen-primed LNC,  LNC  prolifera- 
tion assays were performed as described earlier (2). Briefly, 4  ￿ 
10  s (unless otherwise indicated) LNC from individual mice were 
cultured with 14, 7,  or 3.5  I.tM concentrations ofpeptide 74-96 
or HEL in 0.2 ml/well of HL-1  medium (Ventrex Laboratories 
Inc.,  Portland,  ME),  supplemented with  2  mM  glutamine,  100 
U/nil of penicillin, and 100 I,  tg of streptomycin. All cultures were 
done  in  triplicate. Proliferation was  measured by addition of 1 
I~Ci of [3H]thynfidine for the last 18 h ofa 5-d culture, and the 
incorporation was assayed by scintillation counting. 
T CellHybrids.  10 s  T  hybridoma  cells  were  cultured  with 
various concentrations of the peptide 74-96, or the pepscan pep- 
tides within the sequence 70-104,  or HEL, with 5  ￿  10  s irradi- 
ated BALB/c  spleen cells  as APC  in  0.2  ml of DMEM  (Flow 
Laboratories, Irvine Ayrshire, Scotland) supplemented with 2 nlM 
glutamine,  0.05  mM  2-ME,  100  U/ml  penicillin,  100  ~g/ml 
streptomycin and 10% heat-inactivated fetal calf serum (Hyclone, 
Logan, UT), as described (2,  11). All cultures were performed in 
triplicate. The supernatants collected 24 h later were assayed /'or 
IL-2 activity on  the  IL-2/IL-4-dependent cell line,  HT-2.  1{)  4 
HT-2 cells were cultured with medium alone or supernatants for 
48 h. Proliferation was measured by adding 1 btCi [3H]thymidine 
during the last 18 h of culture and incorporation assayed by liquid 
scintillation counting. 
Results 
We compared T  cell responsiveness in HEL-inmmnized 
H-2 'i mice with and without a wild-type repertoire, to test 
the hypothesis that the lack of 10 TCR  VI3 gene seglnents 
in V[3  ~ mice could result in a hole in the repertoire of regu- 
latory T  cells and lead to a manifestation of T  cell respon- 
siveness to  certain determinants that  are normally nonim- 
munogenic.  For  these  initial  experiments,  we  used  the 
wild-type (v~b), H-2 a haplotype BALB/c mice and the RI, 
H-2 ~ haplotype mice, (CxJ)8 and (CxJ)9, that have a trun- 
cated (V~9  repertoire at their TCR  locus. The  (CxJ)9 and 
(CxJ)8  mice  have  been  described  earlier  (2).  A  pepscan 
analysis (using a series of overlapping peptides that walk the 
whole  antigen  [HELl  in  single anfino  acid steps)  of LNC 
from HEL-primed (CxJ)9  (H-2  d, V~3  '~) and BALB/c (H-2  d, 
V~  b) mice revealed that only V~  a mice were able to respond 
to peptides in the 74-96  region of HEL  (data not shown). 
We  therefore  selected peptide 74-96  (a  tryptic peptide of 
HEL), to further study the differential responsiveness ofV~3 ~' 
and V~  b mice in this haplotype. 
In  the H-2 d Haplotype,  Peptide  HEL  74-96 Induces  T  Cell 
Responses Exclusively  in  Vls" Mice.  Fig.  1  shows  the  re- 
sponses from individual mice  of three different V~  b strains 
(B10.D2, BALB/c, and F1 [BALB/cxSJL], left), and two Vis:' 
strains  ([CxJ]8  and  [CxJ]9;  n[r  H-2 d mice primed with 
peptide HEL 74-96. As the RI (CxJ)8 and (CxJ)9 (V~3  ~', H-2 a) 
mice were originally derived from BALB/c (V~ b) and SjL/J 
(vr  parents,  we chose to  use  F~(BALB/cxSJL,) V~3  b mice 
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Figure 1.  V~  " (truncated TCR 
repertoire)  but  not  vf3b(wild  - 
type  TCR  repertoire)  mice  of 
H-2  a haplotyope  are able to re- 
spond to HEL 74-96,  (a)  16 V~  b 
(B10.D2, BALB/c and  [BALB/c 
￿  (CxJ)9]FI)  mice  and  21  VI3  ~ 
([CxJ]9 and  [CxJ]8), immunized 
with HEL peptide  74-96  in foot 
pads, were tested individually for 
proliferative responses to p74-96 
and  HEL  using  LNC  as  de- 
scribed  earlier  (2). The data are 
represented  as mean cpm  "4- SE 
(X  10  3) from triplicate cultures 
of LNC from each mouse at the 
optimal  concentration  of 7  IxM 
of p74-96  (top) or HEL (bottom). 
LNC tested at concentrations  of 
either 14  or 3.5  btM of peptide 
or HEL gave similar results (data 
not  shown).  The  mean  -+  SE 
values for medium controls  ([~) 
are presented  in front of the bars 
for  p74-96  and  HEL  (11). The 
PPD  values for the first six V~  b 
mice were: (mean --- SE ￿  10 -3) 
210.8  -+  12.2, 203.2  +  3.6, 
228.0  -+  2.2,  193.4  -+  8.0, 
159.8 -+  6.5,  531.7  -+  7.8.  The 
PPD values for the remaining  10 
V~  b mice and the V~  ~ mice were 
in the same range as those for V~  b 
mice (not shown).  (b) LNC from 
three  B10.D2  and  three  (CxJ)9 
mice  immunized  with  p74-96 
were pooled and tested for pro- 
liferative  responses  to  15-mer 
pepscan  peptides  (peptides  cov- 
eting the sequence  HEL 69-104 
in one amino acid step). The data 
are presented as the means of trip- 
licate cultures as described in a. 
in order to  have comparable  strain backgrounds  in the V~  ~ 
and  V~  b groups.  The  results  clearly show  that  none  of the 
16 different V~  b mice primed with peptide 74-96  could re- 
spond  to  the HEL peptide  74-96  when  recalled with pep- 
tide  74-96  (Fig.  1  a,  top  left).  The  mean  delta  counts  per 
minute  (cpm  of LNC  incubated  with  the  peptide  74-96 
minus the cpm of cells incubated medium  alone)  of 21  V~  a 
mice tested individually is  128,000  and that of 16 V~  b mice 
is 5,850. With HEL (Fig. 1 a, bottom left) as the in vitro recall 
antigen,  3  of 10  BALB/c  mice  showed  a  low  level of re- 
sponsiveness.  Surprisingly,  each of the 21  V~  ~ mice, primed 
with  74-96,  showed  strong  T  cell  proliferation  to  both 
peptide  74-96  and  HEL used  as in vitro antigens  (Fig.  1  a, 
right).  Similar results  were  obtained  from  an  additional  10 
V~  u and  10 V~  ~ mice  (data not shown).  HEL was used as a 
recall antigen to ensure  that  T  cells induced by the peptide 
74-96 could be stimulated by the determinant derived from 
natural,  intracellular processing of HEL. A  pepscan  of HEL 
74-96-primed  V~  u and V~  a mice, recalled by sequential  15- 
mer peptides  within  HEL  69-104,  is shown  in  Fig.  1  b.  It 
seems  clear that  (a)  only  T  cells from  V~  ~ mice recognize 
the peptide 74-96 and (b) several determinant cores are rec- 
ognized by T  cells from V~  "~ mice, with peaks at 71-85, 74- 
88,  and 79-93  (Fig.  1 b). 
The  responsiveness  of  (CxJ)8  and  (CxJ)9  mice  might 
have been owing to contribution  of portions of the SJL ge- 
nome found in each of these strains,  other than within the 
V~  ~ region.  However, this is unlikely because of the lack of 
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Figure 2.  Lack  of antigen-spe- 
cific  responses of  LNC  from 
primed V~  b mice is independent 
of cell  numbers used  per  well. 
LNC from four (CxJ)9 V~  ~ (O) 
and 2  BALB/c  [V~  b]  (O)  mice 
were  tested individually  using 
105  , 4  ￿  l0  s  , and 6  ￿  10  s cells 
per well with or without peptide 
74-96  (at 7  ~M).  The data are 
shown  as  stimulation  indices 
(cpm of LNC cultured with pep- 
tide divided by cpm of LNC cul- 
tured with medium alone). 3  ￿ 
l0  s  nomlal  (CxJ)9  or BALB/c 
mice splenic cells were added to 
wells  containing 10  s  respective 
LNC in order to have a minimal 
cell number of 4 ￿  1()  ~ cells per 
well.  The  PP1)  responses  of 
these  mice  were  in  the  same 
range as in Fig. 1. 
74-96-specific T  cell responses found in primed FI(BALB/c X 
SJL)  mice (Fig.  1 a, left). 
Fig.  2  shows  a  titration of LNC  from individual V~3  a or 
V~  b mice primed with peptide 74-96.  It is clear that at  105, 
4  X  10  s and 6  X  10  s cells per well, LNC from V~  a (CxJ)9 
mice showed markedly greater proliferative responses than 
V~  b (BALB/c) mice. 
BALB/c (H-2  a) Mice Are Able to Process and Present Peptide 
74-96 to T Cell Hybrids Derived  from (CxJ)9 Mice and Specific 
for Various Determinants within the Peptide 74-96.  Fig. 3 shows 
the stimulation of four representative 74-96-specific T  cell 
hybridomas derived from (CxJ)9 mice using pepscan analy- 
sis within the sequence 70-104.  The minimal cores recog- 
nized by these T  hybrids are  (clockwise from top left): 77- 
90,  72-85,  71-84,  and  72-84,  respectively.  It is  surprising 
that  72-85,  71-84,  and 72-84  are minimal cores for  the  T 
hybrids derived from mice immunized with peptide 74-96, 
which lacks residues 71  to 73. This result, however, is rem- 
iniscent of and is  consistent with  our recent  report  that  a 
single  TCR  can  be  stimulated  by  multiple  peptide  cores 
(12).  Thus,  it is likely that  72-85,  71-84,  and 72-84  each 
contain one  of the  peptide  cores  recognized by the  latter 
three T  hybrids, respectively. 
As BALB/c  splenic cells were used as APC  in these ex- 
periments, it is evident that BALB/c APC are able to pro- 
cess  and present each  of these determinants to 74-96-spe- 
cific T  cells. Furthermore, each of these T  cell hybridomas 
can be activated by HEL  (data  not shown),  indicating the 
ability  of BALB/c  mice  to  generate  all  the  determinants 
within peptide  74-96,  from the intact protein or from the 
peptide.  We  would like  to  point  out  that  even though  it 
was  possible  to  isolate  74-96-specific  CD4  T  cell  hybrids 
from V~  b BALB/c mice, their cloning efficiency was more 
than 10,000 times lower than that of the cloning efficiency 
of 74-96-specific  T  cell  hybrids from  (CxJ)9  mice  under 
equivalent  conditions  (Nanda,  N.K.,  unpublished  data). 
Cloned T  hybrids derived from BALB/c mice nevertheless 
showed a similar diversity of recognition of different mini- 
real determinants on the peptide 74-96. 
In  Vivo Deletion of CD8  T  Cells Reveals the Expression q[ 
Responsiveness to Peptide 74-96 in  VJ' Mice.  To  explore  the 
possibility that  a  TCR  V~  gene  required  by  a  regulatory 
population and missing in V~  ;~ mice was the cause of the re- 
sponsiveness of (CxJ)9  mice to 74-96, we sought proof for 
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Figure  3.  Different  minimal  determinants  within 
HEL 74-96  can be presented by BALB/c APC.  Data 
from  one representative of two  to  three  experiments 
are shown at the optimal dose of 7 ~M ofpeptides.  T 
hybridoma cells were cultured with irradiated BALB/c 
(H-2 d) spleen cells as APC and different concentrations 
of indicated 15-anfino acid-long pepscan peptides (69- 
83 to 90-104)  and p74-96  as described earlier and in 
Materials and Methods. The supernatants were assayed 
for IL-2 activity on HT-2 cells. The data are expressed 
as mean cpm +  SE of each triplicate culture of HT-2 
cells, minus the medium alone background. 
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Figure 4.  V~  h mice depleted ofCD8 T cells are able to respond to p74- 
96. BALB/c (shown) and (CxJ)9 (not shown) mice were injected intraperi- 
tonealty with either PBS alone or rat lgG2a in PBS, or anti-CD8  anti- 
body in PBS, 4 d before immunization with p74-96. LNC from individual 
mice were tested in vitro for proliferation in response to p74-96 or HEL, 
9 d after immunization as described in Fig. 1. LNC were simultaneously 
analyzed for presence ofCD8 T cells  by immunofluorescence (see lKesults). 
The data are expressed as described in Fig. 1. In vivo depletion ofCD8 T 
cells in (CxJ)9 mice resulted in a slight decrease (10-29%) in 74-96~pe- 
cific responses of their LNC (data not shown). The decrease in prolifera- 
tive responses in (CxJ)9 mice could possibly be due to bystander stimula- 
tion of CD8 T cells and its effects on proliferative T cell responses. 
the  existence  of this  regulatory CD8  population in  wild- 
type V~  b mice.  BALB/c  (V~  b)  mice  were  treated  in  vivo 
with  anti-CD8  antibody  4  d  before  immunization  with 
peptide  74-96.  Mice  treated  with  anti-CD8  antibody 
showed a marked depletion ofCD8 + T  cells: on day 4 after 
anti-CD8  treatment  (at  the  time  mice  were  immunized 
with the peptide), treated mice had <1%  CD8  T  cells. By 
day 13 after the treatment with anti-CD8 antibody (9 d af- 
ter  immunization),  anti-CD8-treated  mice  had  regained 
2.8-4%  of their CD8 + T  cells, whereas  mice treated with 
isotype control antibody rlgG2a had 13-15% CD8 + T  cells 
(data not shown) in their LNC. 
It is evident from Fig. 4 that each of the seven anti-CD8 
antibody-treated BALB/c mice showed a  considerable re- 
sponsiveness to peptide 74-96,  whereas  those treated with 
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PBS or an isotype control antibody remained unresponsive 
to this determinant.  The mean delta counts per minute  of 
three BALB/c mice treated with PBS is 5,040, that of three 
BALB/c  mice  treated  with  control  antibody  (rIgG2b)  is 
6,270,  and  that  of seven BALB/c  mice  treated with  anti- 
CD8  antibody is  63,140.  Anti-CD8-treated,  peptide  74- 
96-immunized  BALB/c  (V~  b)  mice  showed  generally 
lower in  vitro recall responses to  the whole protein HEL 
than V~  ~ mice (see Fig. 1 a). 
Discussion 
It is evident that constraints in T  cell recognition would 
create gaps not  only in the direct repertoire of responsive 
cells  but  also  in  the  repertoire  of regulatory  cells  (2,  3). 
Thus,  the  absence  of 10  TCR  V~  gene  segments  in  V~  a 
mice resulted in a hole in the repertoire of CD4 T  cell im- 
mune responses to two antigenic determinants, SWM 110- 
121/E~dA~  d and MBP 1-11/A  u (2). We now show that V~  a 
mice  with  a  truncated  repertoire  of TC1K  V~  gene  seg- 
ments also have a hole in the repertoire of their regulatory 
CD8  T  ceils that results in disclosing an underlying T  cell 
imnmne responsiveness to HEL 74-96/A  d. The response to 
this determinant is absent in the wild-type mice displaying 
a  complete repertoire of TClK Vf~ gene segments.  CD8  T 
cell ablation in  these  wild-type mice,  however,  results in 
expression of 74-96--specific T  cell responses. Thus, lack of 
responsiveness in the V~  b mice cannot be attributed to the 
absence of a  74-96--specific CD4  T  cell repertoire or to a 
defect in antigen processing. 
This  report  is  a  first  demonstration  of expression  of a 
CD4 T  cell response to a peptide determinant in wild-type 
mice by simple in  vivo ablation of CD8  T  cells. CD8  T 
cells have  been  implicated in  downregulation  of immune 
responses in several systems over the last two  decades  (for 
reviews see references 13 and 14). Most of these studies in- 
volved complicated in vitro cell reconstitution experiments 
(13,  14)  or adoptive transfer systems (15).  Moreover, these 
studies focussed on  experimental inhibition of either T  or 
B  cell function, which is distinct from our system in which 
the  Vf~  b,  H-2 d mice  do  not  respond  upon  immunization 
with peptide 74-96 of HEL with CFA, a traditionally pow- 
erful immunization regimen. In addition, the expression of 
CD4  T  cell responses in V~  ~ mice, without  having to de- 
plete T  cells, involved no experimental manipulation. Our 
results are aligned with more recent observations where the 
direct approach of in vivo CD8  T  cell depletion was used 
in the murine experimental autoimmune encephalomyelitis 
(EAE) model (B10.PL,  H-2 u mice), and shown to result in 
inducing chronicity of disease as well as a lack of resistance 
to a second induction of disease in these mice (16). Similar 
results  were  obtained  using  mutant  (CD8 -/-)  mice  that 
lack the  CD8  gene  and  therefore  CD8  T  cells.  CD8  /- 
mice  undergo  more relapses of EAE  than  wild-type mice 
immunized by MBP  (17).  These experiments showed that 
CD8  T  cells,  under  normal  circumstances,  downregulate 
the function of autoimmune  CD4 T  cells and thus prevent 
relapses or reinduction of EAE. Why do V~fl, H-2  a mice respond to immunization with 
peptide HEL 74-96 without having been depleted of CD8 
T  cells? As discussed above, one reason could be the contri- 
bution of some genes (other than the TCR genes) from the 
SJL parent of the RI(CxJ)9 and (CxJ)8 mice (as these mice 
were  derived  from BALB/c  and  SJL  grandparents).  This 
appears  unlikely  as  (BALB/c  ￿  SJL)FI,  H-2  axs mice  (ex- 
pressing all genes contributed by the SJL parent)  are unable 
to respond to peptide 74-96. Another reason could be that 
the  (CxJ)9  and  (CxJ)8  mice  express  quantitatively  smaller 
amounts  of a  self-superantigen-like  gene  product  which, 
when expressed in larger amounts in BALB/c mice, results 
in  the  deletion  of HEL 74-96-specific  CD4  T  ceils.  The 
absence  of 74-96-specific  T  cell  deletion  in  (CxJ)9  and 
(CxJ)8 mice could conceivably enable  them to respond to 
HEL 74-96.  This  is  very unlikely  because  BALB/c  mice 
are  able  to  respond  to  HEL 74-96  after  having been  de- 
pleted of  CD8  T  cells.  Our  results  favor the  explanation 
that the lack ofT cell responses to HEL 74-96 in wild-type 
V~  b mice and  their  expression  in Vffl mice is solely deter- 
mined by the TCR  V~ locus: it is the lack of 10 TCR  V~ 
gene  segments  underlying  the  existence  of a  regulatory 
contingent,  that leads to responsiveness  in V~3  a mice with- 
out having to deplete them of CD8 T  cells.  These CD8 T 
cells  able  to downregulate  74-96-specific  T  cell  responses 
are present in the wild-type mice and are missing in (CxJ)9 
and  (CxJ)8  mice because of the  absence of a critical TCtL 
V~3 gene segment in these mice.  It is likely that further ex- 
amples of neo-responses to determinants  on other antigens 
will be detected in such mice. 
Our  results  present  evidence  that  deletion  of multiple 
TCR. V~3 gene segments in an individual can not only result 
in a lack ofimmunogenicity, as shown earlier,  but also in a 
gain  of immunogenicity  to  an  antigenic  determinant,  as 
shown in  the  current  report  (also  discussed  in  2).  During 
evolution,  a balance between  these  opposite  repercussions 
from a loss ofTCR  VI3 gene segments may have resulted in 
expression  of different  numbers  of deletion  ligands  (self- 
superantigens) in different strains of mice, leading to a spec- 
trum of possibilities  of loss of TCR  V~ segments across the 
species (18,  19), which in turn results in gain or loss ofim- 
munogenicity to different antigenic determinants in different 
strains.  In  addition,  these  results  provide  direct  evidence 
that peripheral  tolerance to specific antigenic  determinants 
can be mediated by CD8 T  cells  and can be overcome by 
in vivo depletion ofCD8 T  cells. 
What is the  mechanism by which CD8  T  cells  prevent 
the  expression  of HEL  74-96-specific  CD4  T  cell  re- 
sponses in wild-type mice? The answer is unclear. We have 
now succeeded in isolating cloned CD8 T  cell hybridomas 
specific  for  HEL  74-96  from  wild-type  BALB/c  mice 
(Nanda,  K. et al.,  unpublished observations).  Our prelimi- 
nary  results  have  revealed  that  these  CD8  T  ceils  are 
unique in possessing a distinct set of requirements  for acti- 
vation  as  compared with  conventional,  cytotoxic CD8  T 
cells.  For example, irradiated splenic APC are unable to ac- 
tivate  these  CD8 T  cells.  Whether  or not,  and how these 
cells  downregulate  HEL 74-96~pecific  CD4  T  cells,  re- 
main to be learned. 
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